Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

J. Whang-Peng; D. E. Lees; W. H. Schuette; R. Smith; J. M. Bull; V. T. DeVita

Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

J. Whang-Peng, D. E. Lees, W. H. Schuette, R. Smith, J. M. Bull, V. T. DeVita

研究成果: 雜誌貢獻 › 文章 › 同行評審

摘要

The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

原文	英語
頁（從 - 到）	1103-1104
頁數	2
期刊	Cancer Treatment Reports
卷	65
發行號	11-12
出版狀態	已發佈 - 12月 1 1981
對外發佈	是

ASJC Scopus subject areas

腫瘤科
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

其它文件與鏈接

Link to publication in Scopus

引用此

@article{8bede756c7e141688351403fff0679c1,

title = "Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy",

abstract = "The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.",

author = "J. Whang-Peng and Lees, {D. E.} and Schuette, {W. H.} and R. Smith and Bull, {J. M.} and DeVita, {V. T.}",

year = "1981",

month = dec,

day = "1",

language = "English",

volume = "65",

pages = "1103--1104",

journal = "Cancer Treatment Reports",

issn = "0361-5960",

publisher = "Oxford University Press",

number = "11-12",

}

TY - JOUR

T1 - Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

AU - Whang-Peng, J.

AU - Lees, D. E.

AU - Schuette, W. H.

AU - Smith, R.

AU - Bull, J. M.

AU - DeVita, V. T.

PY - 1981/12/1

Y1 - 1981/12/1

N2 - The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

AB - The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

UR - http://www.scopus.com/inward/record.url?scp=0019773176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019773176&partnerID=8YFLogxK

M3 - Article

C2 - 7296555

AN - SCOPUS:0019773176

SN - 0361-5960

VL - 65

SP - 1103

EP - 1104

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

IS - 11-12

ER -

Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

摘要

ASJC Scopus subject areas

UN SDG

其它文件與鏈接

指紋

引用此